Michael Golembiewski - Chief Financial Officer at Seelos Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Financial Officer
Stock Symbol
SEEL on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Michael Golembiewski since 12/17/2023

Holdings reported by Michael Golembiewski for Seelos Therapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 86.9K $95.3K $1.10 Feb 29, 2024 Direct
Stock Option (right to buy) 24.5K Jan 12, 2024 Direct Common Stock

Transactions reported by Michael Golembiewski for Seelos Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.